Researchers utilize funtional test to quantify the impact of inhertited varient in BRCA2 acancer gene Kumar Jeetendra | February 21, 2021 Researchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variations in the BRCA2 breast and ovarian cancer gene with clinical information from women who received genetic testing to determine the clinical importance of many BRCA2 variants of uncertain significance (VUS). The findings were published today in a study …
New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian disease Kumar Jeetendra | June 12, 2021 Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced effective results, dramatically restricting tumor growth and diminishing tumor mass. Designed especially for ovarian cancers that are resistant to conventional therapies, the new radiopharmaceutical could be produced in 25 minutes at reduced cost, which contributes to better efficiency compared with alternative procedures. This …
